Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background On the basis of the mounting evidence that type 17 T (T17) cells and increased IL-17 play a key role in driving hidradenitis suppurativa (HS) lesion development, biologic agents used previously in psoriasis that block signaling of IL-17A and/or IL-17F isoforms have been repurposed to treat HS. Objective Our research aimed to characterize the transcriptome of HS T17 cells compared to the transcriptome of psoriasis T17 cells, along with their ligand–receptor interactions with neighborhood immune cell subsets. Methods Single-cell data of 12,300 cutaneous immune cells from 8 deroofing surgical HS skin samples including dermal tunnels were compared to single-cell data of psoriasis skin (19,525 cells from 11 samples) and control skin (11,920 cells from 10 samples). All single-cell data were generated by the same protocol. Results HS T17 cells expressed lower levels of IL23R and higher levels of IL1R1 and IL17F compared to psoriasis T17 cells ( P < .05). HS Treg cells expressed higher levels of IL1R1 and IL17F compared to psoriasis Treg cells ( P < .05). Semimature dendritic cells were the major immune cell subsets expressing IL1B in HS, and IL-1β ligand–receptor interactions between semimature dendritic cells and T17 cells were increased in HS compared to psoriasis ( P < .05). HS dermal tunnel keratinocytes expressed inflammatory cytokines ( IL17C, IL1A, IL1B, and IL6 ) that differed from the HS epidermis keratinocytes ( IL36G ) ( P < .05). IL6, which synergizes with IL1B to maintain cytokine expression in T17 cells, was mainly expressed by fibroblasts in HS, which also expressed IL11 + inflammatory fibroblast genes ( IL11, IL24, IL6, and POSTN ) involved in the paracrine IL-1/IL-6 loop. Conclusion The IL-1β–T17 cell cytokine axis is likely a dominant pathway in HS with HS T17 cells activated by IL-1β signaling, unlike psoriasis T17 cells, which are activated by IL-23 signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055
Watanabe, R., Gehad, A., Yang, C., Scott, L. L., Teague, J. E., Schlapbach, C., Elco, C. P., Huang, V., Matos, T. R., Kupper, T. S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010302 · Cited by 569
Kimball, A. B., Jemec, G. B. E., Alavi, A., Reguiai, Z., Gottlieb, A. B., Bechara, F. G., Paul, C., Giamarellos Bourboulis, E. J., Villani, A. P., Schwinn, A., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00022-3 · Cited by 343
Matusiak, Ł., Szczęch, J., Bieniek, A., Nowicka-Suszko, D., & Szepietowski, J. C. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.042 · Cited by 185
Cited by
Th17 cell pathogenicity in autoimmune disease
Park, E., & Ciofani, M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01535-9 · Cited by 75
Transcriptomic Signatures and Molecular Pathways in Hidradenitis Suppurativa—A Narrative Review
Spiteri, J., Mintoff, D., Grech, L., & Pace, N. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167704 · Cited by 10
Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
Vecin, N., Balukoff, N. C., Yaghi, M., Gonzalez, T., Sawaya, A. P., Strbo, N., Tomic-Canic, M., Lev-Tov, H., & Pastar, I. (2025) · JID Innovations · doi:10.1016/j.xjidi.2025.100350 · Cited by 10
Metadata
- Authors
- Kim, J., Lee, J., Li, X., Lee, H. S., Kim, K., Chaparala, V., Murphy, W., Zhou, W., Cao, J., Lowes, M. A., & Krueger, J. G.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 152
- Issue
- 3
- Pages
- 656-666
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W4379376898
- Cited by
- 91
- References
- 4
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.